Correlation Between Willow Biosciences and Cansortium

Can any of the company-specific risk be diversified away by investing in both Willow Biosciences and Cansortium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Willow Biosciences and Cansortium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Willow Biosciences and Cansortium, you can compare the effects of market volatilities on Willow Biosciences and Cansortium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Willow Biosciences with a short position of Cansortium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Willow Biosciences and Cansortium.

Diversification Opportunities for Willow Biosciences and Cansortium

0.81

Correlation Coefficient

Willow Biosciences  Cansortium

Very poor diversification

The 3 months correlation between Willow and Cansortium is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Willow Biosciences and Cansortium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cansortium and Willow Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Willow Biosciences are associated (or correlated) with Cansortium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cansortium has no effect on the direction of Willow Biosciences i.e., Willow Biosciences and Cansortium go up and down completely randomly.

Pair Corralation between Willow Biosciences and Cansortium

Assuming the 90 days horizon Willow Biosciences is expected to generate 0.72 times more return on investment than Cansortium. However, Willow Biosciences is 1.38 times less risky than Cansortium. It trades about -0.06 of its potential returns per unit of risk. Cansortium is currently generating about -0.12 per unit of risk. If you would invest  7.90  in Willow Biosciences on September 16, 2024 and sell it today you would lose (2.30) from holding Willow Biosciences or give up 29.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Willow Biosciences  vs.  Cansortium

Willow Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Willow Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Cansortium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cansortium has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Willow Biosciences and Cansortium

The main advantage of trading using opposite Willow Biosciences and Cansortium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Willow Biosciences position performs unexpectedly, Cansortium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cansortium will offset losses from the drop in Cansortium's long position.

The idea behind Willow Biosciences and Cansortium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.